Demis Hassabis, CEO of DeepMind, revealed that AI can drastically shorten drug discovery timelines, potentially reducing ...

The global drug discovery services market is projected to grow at a CAGR of 15% from 2025 to 2030. This growth is driven by ...

In the evolving landscape of drug development, Multi-Target Drug Discovery (MTDD) has emerged as a promising strategy for ...

The compounds that emerge aren't just theoretical curiosities. They're synthesised and tested, and one targeting fibrosis ...

The world of medicine has taken a significant leap forward with the first AI-generated drug entering clinical trials. This breakthrough has the potential to revolutionize drug discovery, transforming ...

AI is already rapidly redefining how we discover and design biologics, and as CTO at Cytiva, I’ve had the privilege of ...

The U.S. large molecule drug discovery outsourcing market, valued at USD 968.60 million in 2024, is set to grow with a 9.20% ...

Artificial intelligence could reduce drug discovery from years to months, according to Demis Hassabis, CEO of Isomorphic Labs ...

The Drug Discovery Outsourcing Market is set to grow at a 7.2% CAGR, driven by advanced technologies and increased demand for specialized expertise. NEWARK, DE, UNITED STATES, September 11, 2025 ...

Southwest Research Institute scientists developed a new purification technique to improve chromatography results without expensive purification materials or equipment. Chromatography is an essential ...

Discovering new drugs is an expensive proposition. From 2012 to 2022, adjusting for inflation, spending on pharmaceutical research and development increased by almost half to roughly $250bn, according ...

A new AI Drug Discovery tool called PDGrapher can predict more accurate drug combinations up to 25 times faster than previous ...